See also this year's filing and all EDGAR filings for this company.
PDF Report 0001703057_2026_Abcellera_Biologics_Inc.pdf
Logs
Graph
Absolute values for 0001703057, Abcellera Biologics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 728,232,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 86,187,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 542,531,000 |
| 4 | LiabilitiesCurrent | 64,307,000 |
| 5 | LiabilitiesNoncurrent | 325,739,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 90,063,329 |
| 9 | ResearchAndDevelopmentExpense | 205,188,330 |
| 10 | remainder_Expenses | 8,222,119 |
| 11 | remainder_Revenues | 74,575,120 |
| 12 | remainder_NetIncome | 56,388,061 |
| 13 | remainder_ComprehensiveNetIncome | -2,655,723 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,356,950,000 |
| 1 | Liabilities | 390,046,000 |
| 2 | Expenses | 303,473,778 |
| 3 | Revenues | 74,575,120 |
| 4 | StockholdersEquity | 966,904,000 |
| 5 | NetIncome | -172,510,597 |
| 6 | ComprehensiveNetIncome | -173,838,458 |
| 7 | BaseVar | 1,092,044,341 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.21 |
| 9 | EconomicCapitalRatio | 3.17 |